查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
載體篩查市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按類型、按篩查類型、按技術、按適應症、按終端用戶、按公司和按地區分類
市場調查報告書
商品編碼
1289643

載體篩查市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按類型、按篩查類型、按技術、按適應症、按終端用戶、按公司和按地區分類

Carrier Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type, By Screening Type, By Technology, By Indication, By End User, By Company, and By Region
出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在2023-2027年的預測期內，全球攜帶者篩查市場預計將出現令人印象深刻的成長。主要因素包括遺傳病的發生率不斷增加，對早期檢測和預防的重視程度不斷提高，以及基因組學領域的技術發展，這些都在推動著市場的成長。遺傳病是由於正常DNA序列的突變而引起的疾病。載體篩查是一種有助於了解孩子患有遺傳性疾病的風險的測試。它確定一個健康人是否含有遺傳病的隱性基因，如鐮狀細胞病、囊性纖維化和其他。支持市場成長的其他因素有：政府對研究和開發活動的投資增加，新的攜帶者篩查測試的大量發布和批准的增加，全球出生率的增加，對個性化醫療的關注增加，人口中攜帶者篩查意識的增加，產婦年齡的增加，大規模基因測試項目的可用性，以及染色體疾病的高發病率。

遺傳性疾病發病率的上升

基因或染色體突變促使的遺傳性疾病和胎兒染色體異常的發病率上升，促進了全球市場的成長。例如，在美國，遺傳性疾病是新生兒死亡的主要原因，佔每年嬰兒死亡率的近20%。遺傳性疾病，如囊性纖維化、Tay-Sachs病和鐮狀細胞貧血症，是由於父母存在可遺傳的基因條件，可能會被後代繼承。根據世界衛生組織（WHO）的數據，在2019年，大約有2-5%的嬰兒患有遺傳病或染色體異常。由於新生兒殘疾的發生率越來越高，產前檢測需求的激增正在推動市場的成長。

對複雜遺傳病的早期檢測和預防的重視程度不斷提高

近年來，人們對遺傳性疾病有了更多的了解，這使他們能夠計劃並更好地照顧他們的嬰兒。城市父母越來越傾向於推遲生育，母親的平均年齡也越來越高，促使懷孕併發症，這是促進市場成長的一個因素。早期檢測有助於夫妻雙方在懷孕的早期階段了解孩子患有遺傳病或疾病的風險。因此，對早期檢測和預防複雜的遺傳性疾病的日益重視，正在推動全球市場的成長。政府和非政府組織為早期攜帶者篩查採取了各種計劃。例如，在2018年，迪拜衛生當局推出了"第一步新生兒篩查"。

技術進步推動市場成長。

基因組學領域採用先進技術的增加正在增強市場的成長。由於載體篩選方法的技術進步，測試技術正變得更加可靠和方便。例如，2022年，美國科學產品供應商賽默飛世爾科技公司宣布推出基於NGS的測試套件，這是一種單一解決方案的載體篩選方法，有助於掃描遺傳疾病，包括基因表達。

可用的定製產品

利用給定的市場數據，TechSci Research根據公司的具體需求提供定製服務。該報告有以下定製選項：

公司資訊

  • 對其他市場參與者（最多5家）的詳細分析和剖析。

目錄

第一章：產品概述

第二章：研究方法

第三章：執行摘要

第四章：COVID-19對全球載體篩查市場的影響

第五章：客戶的聲音

第六章：全球載體篩查市場前景

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按類型（擴大的攜帶者篩查v/ 目標癌症篩查）
    • 按篩查類型（產前載體檢測v/ 孕前載體篩查）
    • 按技術分類（下一代測序、聚合酶鍊式反應、微陣列、其他）
    • 按適應症（囊性纖維化、唐氏綜合症、地中海貧血、泰-薩克斯病、亨廷頓病、鐮狀細胞性貧血、其他）
    • 按終端用戶（醫院和診所、參考實驗室、其他）分類
    • 按地區
    • 按公司分類（2021年）
  • 市場地圖

第七章：北美載體篩查市場前景

  • 市場規模和預測
    • 按價值分類
  • 市場佔有率和預測
    • 按類型
    • 按篩查類型
    • 按技術分類
    • 按適應症分類
    • 按終端用戶分類
    • 按國家分類
  • 北美洲：國家分析
    • 美國
    • 美國
    • 墨西哥

第8章：歐洲載體篩查市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按類型
    • 按篩查類型
    • 按技術分類
    • 按適應症分類
    • 按終端用戶分類
    • 按國家分類
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第九章：亞太地區載體篩查市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按類型
    • 按篩查類型
    • 按技術分類
    • 按適應症分類
    • 按終端用戶分類
    • 按國家分類
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第十章：南美載體篩查市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按類型
    • 按篩查類型
    • 按技術分類
    • 按適應症分類
    • 按終端用戶分類
    • 按國家分類
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章：中東和非洲載體篩查市場前景

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按類型
    • 按篩查類型
    • 按技術分類
    • 按適應症分類
    • 按終端用戶分類
    • 按國家分類
  • MEA: 國家分析
    • 南非載體篩查
    • 沙烏地阿拉伯載體篩查
    • 阿拉伯聯合大公國的載體篩查

第十二章：市場動態

  • 驅動因素
  • 挑戰

第十三章：市場趨勢和發展

第十四章：競爭格局（包括SWOT分析）

  • Eurofins Scientific, Inc.
  • Fulgent Genetics, Inc.
  • CENTOGENE NV
  • Invitae公司
  • Illumina, Inc.
  • Gene by Gene, Ltd. (基因公司)
  • 美國實驗室公司控股
  • Natera, Inc.
  • Myriad Genetics, Inc.
  • Quest Diagnostics, Inc.

第十五章：戰略建議

簡介目錄
Product Code: 13043

The global carrier screening market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include increasing occurrences of genetic conditions, rising emphasis on early detection and prevention, and technological developments in the field of genomics that are fueling the growth of the market. Genetic conditions are diseases caused due to mutations in the normal DNA sequence. Carrier screening is a kind of test that helps to know the risk of having a child with a genetic disorder. It determines whether a healthy person contains the recessive gene of genetic diseases such as sickle cell disease, cystic fibrosis, and others. The other factors supporting the market's growth are rising investments in research and developments activities by the government, rise in numerous releases and approvals of new carrier screening tests, increasing birth rate across the globe, rising focus on personalized medicine, growing awareness of carrier screening among the population, increasing maternal age, availability of mass genetic testing programs, and the high incidence of chromosomal disorders.

Rising Prevalence of Genetic Diseases

The rising incidences of genetic disorders and fetal chromosomal anomalies due to mutation in genes or chromosomes are bolstering the growth of the market globally. For instance, in the U.S., genetic diseases are the primary cause of newborn deaths, accounting for nearly 20% of annual infant mortality. Genetic diseases such as cystic fibrosis, Tay-Sachs disease, and sickle cell anemia occur due to inheritable genetic conditions present in parents, which may get inherited by the offspring. According to the World Health Organization (WHO), in 2019, about 2 to 5% of infants had genetic diseases or chromosomal abnormalities. Owing to the increasing occurrences of disabilities in newborns, the surge in demand for prenatal testing is propelling the growth of the market.

Rising Emphasis on Early Detection and Prevention of Complex Genetic Disorders

In recent years, people have become more aware of genetic disorders, which enables them to plan and take better care of their babies. The growing inclination among urban parents to delay childbearing and the higher average age of mothers lead to pregnancy complications, which is a contributing factor to facilitating the growth of the market. Early detection helps couples to know the risk of having a child with genetic diseases or disorders in an early stage of pregnancy. Thus, the rising focus on early detection and prevention of complex genetic disorders is fueling the growth of the market globally. Various initiatives are taken by government and non-government organizations for early carrier screening. For instance, in 2018, "Step One Newborn Screening" was introduced by the Dubai health authority.

Technological Advancements fuel the Market Growth.

The rise in the adoption of advanced technology in the field of genomics sector is augmenting the growth of the market. The testing techniques are becoming more reliable and convenient because of technological advancements in carrier screening methods. For instance, in 2022, Thermo Fisher Scientific Inc., an American supplier of scientific products, announced the launch of an NGS-based test kit, which is a type of carrier screening approach in single solution that assists in scanning genetic disorders, including gene expression.

Market Segmentation

The global carrier screening market is segmented into type, screening type, technology, indication, end user, and company. Based on type, the market is divided into expanded carrier screening and targeted cancer screening. Based on screening type, the market is divided into prenatal carrier testing and preconception carrier screening. Based on technology, the market is divided into next-generation sequencing, polymerase chain reaction, microarrays, and others. Based on indication, the market is divided into cystic fibrosis, down's syndrome, thalassemia, tay sachs disease, Huntington's disease, sickle cell anemia, and others. Based on end-user, the market is divided into hospitals & clinics, reference laboratories, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the increasing incidences of genetic conditions and technological advancements in the country.

Market Players

Eurofins Scientific, Inc., Fulgent Genetics, Inc., CENTOGENE N.V., Invitae Corporation, Illumina, Inc., Gene by Gene, Ltd., Laboratory Corporation of America Holdings, Natera, Inc., Myriad Genetics, Inc., and Quest Diagnostics, Inc are some of the leading companies operating in the market.

Report Scope

In this report, global carrier screening market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Carrier Screening Market, By Type:

  • Expanded Carrier Screening
  • Targeted Cancer Screening

Carrier Screening Market, By Screening Type:

  • Prenatal Carrier Testing
  • Preconception Carrier Screening

Carrier Screening Market, By Technology:

  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Microarrays
  • Others

Carrier Screening Market, By Indication:

  • Cystic Fibrosis
  • Down's Syndrome
  • Thalassemia
  • Tay-Sachs Disease
  • Huntington's Disease
  • Sickle Cell Anemia
  • Others

Carrier Screening Market, By End User:

  • Hospitals & Clinics
  • Reference Laboratories
  • Others

Carrier Screening Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Carrier Screening Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Carrier Screening Market

5. Voice of Customer

6. Global Carrier Screening Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Expanded Carrier Screening v/s Targeted Cancer Screening)
    • 6.2.2. By Screening Type (Prenatal Carrier Testing v/s Preconception Carrier Screening)
    • 6.2.3. By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Microarrays, Others)
    • 6.2.4. By Indication (Cystic Fibrosis, Down's Syndrome, Thalassemia, Tay-Sachs Disease, Huntington's Disease, Sickle Cell Anemia, Others)
    • 6.2.5. By End User (Hospitals & Clinics, Reference Laboratories, Others)
    • 6.2.6. By Region
    • 6.2.7. By Company (2021)
  • 6.3. Market Map

7. North America Carrier Screening Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Screening Type
    • 7.2.3. By Technology
    • 7.2.4. By Indication
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Carrier Screening Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Screening Type
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Indication
        • 7.3.1.2.5. By End User
    • 7.3.2. Canada Carrier Screening Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Screening Type
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Indication
        • 7.3.2.2.5. By End User
    • 7.3.3. Mexico Carrier Screening Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Screening Type
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Indication
        • 7.3.3.2.5. By End User

8. Europe Carrier Screening Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Screening Type
    • 8.2.3. By Technology
    • 8.2.4. By Indication
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Carrier Screening Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Screening Type
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Indication
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Carrier Screening Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Screening Type
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Indication
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Carrier Screening Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Screening Type
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Indication
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Carrier Screening Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Screening Type
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Indication
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Carrier Screening Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Screening Type
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Indication
        • 8.3.5.2.5. By End User

9. Asia-Pacific Carrier Screening Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Screening Type
    • 9.2.3. By Technology
    • 9.2.4. By Indication
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Carrier Screening Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Screening Type
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Indication
        • 9.3.1.2.5. By End User
    • 9.3.2. India Carrier Screening Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Screening Type
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Indication
        • 9.3.2.2.5. By End User
    • 9.3.3. Japan Carrier Screening Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Screening Type
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Indication
        • 9.3.3.2.5. By End User
    • 9.3.4. South Korea Carrier Screening Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Screening Type
        • 9.3.4.2.3. By Technology
        • 9.3.4.2.4. By Indication
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Carrier Screening Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Screening Type
        • 9.3.5.2.3. By Technology
        • 9.3.5.2.4. By Indication
        • 9.3.5.2.5. By End User

10. South America Carrier Screening Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Screening Type
    • 10.2.3. By Technology
    • 10.2.4. By Indication
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Carrier Screening Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Screening Type
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Indication
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Carrier Screening Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Screening Type
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Indication
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Carrier Screening Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Screening Type
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Indication
        • 10.3.3.2.5. By End User

11. Middle East and Africa Carrier Screening Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Screening Type
    • 11.2.3. By Technology
    • 11.2.4. By Indication
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Carrier Screening Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Screening Type
        • 11.3.1.2.3. By Technology
        • 11.3.1.2.4. By Indication
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Carrier Screening Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Screening Type
        • 11.3.2.2.3. By Technology
        • 11.3.2.2.4. By Indication
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Carrier Screening Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Screening Type
        • 11.3.3.2.3. By Technology
        • 11.3.3.2.4. By Indication
        • 11.3.3.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape (Inclusive of SWOT Analysis)

  • 14.1. Eurofins Scientific, Inc.
  • 14.2. Fulgent Genetics, Inc.
  • 14.3. CENTOGENE N.V.
  • 14.4. Invitae Corporation
  • 14.5. Illumina, Inc.
  • 14.6. Gene by Gene, Ltd.
  • 14.7. Laboratory Corporation of America Holdings
  • 14.8. Natera, Inc.
  • 14.9. Myriad Genetics, Inc.
  • 14.10. Quest Diagnostics, Inc.

15. Strategic Recommendations